These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31892984)

  • 1. Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis.
    Zhang L; Wang Y; Qin Z; Gao X; Xing Q; Li R; Wang W; Song N; Zhang W
    J Cancer; 2020; 11(1):177-189. PubMed ID: 31892984
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
    Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
    Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients.
    Kim SH; Kwon WA; Joung JY
    World J Mens Health; 2021 Apr; 39(2):358-365. PubMed ID: 32202082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.
    Freitas D; Andriole GL; Freedland SJ; Neto BS; Moreira DM
    Urology; 2019 Jul; 129():160-164. PubMed ID: 30914334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.
    He J; Han Z; Luo W; Shen J; Xie F; Liao L; Zou G; Luo X; Guo Z; Li Y; Li J; Chen H
    Front Immunol; 2022; 13():998447. PubMed ID: 36685547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Evidence of Helicobacter Pylori Infection in Prostate Tumors.
    Al-Marhoon MS; Ouhtit A; Al-Abri AO; Venkiteswaran KP; Al-Busaidi Q; Mathew J; Al-Haddabi I; Shareef O; Aquil S; Rahman K; Al-Hashmi I; Gupta I; Ganguly SS
    Curr Urol; 2015 Sep; 8(3):138-43. PubMed ID: 26889133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
    De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
    Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy.
    De Luca S; Passera R; Fiori C; Bollito E; Cappia S; Mario Scarpa R; Sottile A; Franco Randone D; Porpiglia F
    Urol Oncol; 2015 Oct; 33(10):424.e17-23. PubMed ID: 26162485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of androgen receptor CAG repeats with the risks of benign prostatic hyperplasia and prostate cancer: a meta-analysis].
    Wang XM; Sun L; Zhang Z; Shi XH; Zhang YG; Wei D; Wan B; Yang Z; Wang JY
    Zhonghua Nan Ke Xue; 2014 Feb; 20(2):172-6. PubMed ID: 24520673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer].
    Zhang F; Si-Mu-Jiang-Abula A; Zhang LD
    Zhonghua Nan Ke Xue; 2014 Apr; 20(4):354-8. PubMed ID: 24873164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal association between prostatitis and development of benign prostatic hyperplasia.
    St Sauver JL; Jacobson DJ; McGree ME; Girman CJ; Lieber MM; Jacobsen SJ
    Urology; 2008 Mar; 71(3):475-9; discussion 479. PubMed ID: 18342190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk.
    Hung SC; Lai SW; Tsai PY; Chen PC; Wu HC; Lin WH; Sung FC
    Br J Cancer; 2013 May; 108(9):1778-83. PubMed ID: 23612451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between MMP-2 expression and prostate cancer: A meta-analysis.
    Xie T; Dong B; Yan Y; Hu G; Xu Y
    Biomed Rep; 2016 Feb; 4(2):241-245. PubMed ID: 26893846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.
    Dai X; Fang X; Ma Y; Xianyu J
    Medicine (Baltimore); 2016 May; 95(18):e3493. PubMed ID: 27149447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology of nonspecific granulomatous prostatitis with special reference to eosinophilic epithelial metaplasia: Pathophysiologic, diagnostic and differential diagnostic correlations.
    Dikov DI; Koleva MS; Boivin JF; Lisner T; Belovezhdov VT; Sarafian V
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S34-S40. PubMed ID: 32108624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer.
    Glaser A; Shi Z; Wei J; Lanman NA; Ladson-Gary S; Vickman RE; Franco OE; Crawford SE; Lilly Zheng S; Hayward SW; Isaacs WB; Helfand BT; Xu J
    Eur Urol Open Sci; 2022 Sep; 43():54-61. PubMed ID: 36353071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.